Bardoc Gold Ltd (ASX:BDC) (FRA:4SF) has taken another key step towards the financing and development of its flagship 100%-owned Bardoc Gold Project in WA, entering into a binding agreement with leading global minerals trader MRI Trading AG for the sale of gold concentrates.
The offtake agreement, which covers around 50% of the forecast life-of-mine (LOM) gold production expected to start at year three from the project, represents a further important step towards establishing the company as a significant new mid-tier Australian gold producer in WA's Eastern Goldfields.
“Solid foundation for debt funding”
Bardoc chief executive officer Robert Ryan said the negotiation of the offtake agreement represented a significant de-risking milestone in the development of the +100,000 ounce per annum project and provided a solid foundation for its project debt funding strategy.
He said: “This is a really important milestone which follows an exhaustive off-taker selection process and we are absolutely delighted to announce MRI as our offtake partner for gold concentrate.”
“This highly detailed and informative process has resulted in very competitive off-take terms with regard to both valuable metal payables and associated costs, as well as favourable payment and shipping terms.
“This process also highlighted the extensive Western Australian experience and global reach of our offtake partner MRI.
“We are pleased to be partnering with a proven group, who are the world’s largest independent trader of non-ferrous concentrates.”
Project location plan
Offtake agreement terms
The execution of the agreement follows the delivery of a pre-feasibility study (PFS) in March which outlined average gold sales of 135,000 ounces per annum over seven years of mill production resulting in an NPV (pre-tax 8%) of A$332 million and 32% IRR based on a A$2,100/ounce gold price and pre-production capital of A$142.4 million.
A comprehensive metallurgy test-work program has demonstrated a simple bulk sulphide flotation flowsheet produces a consistent flotation response and a high gold recovery to concentrate across the entire Aphrodite deposit.
The terms of the binding offtake agreement remain confidential but combined with the detailed metallurgical test-work, compares extremely favourably to the PFS with:
- Gold concentrate expected to run up to 100 g/t;
- Total gold recovery and payable of 92% compared with the assumptions in the PFS of 85%; and
- Unit treatment cost below the assumptions in the PFS.
Next steps
The companies will now move to full form documentation for a formal offtake agreement in parallel with the project debt financing.
Bardoc will also move towards the conclusion of resource drilling and assaying program for the cornerstone Zoroastrian and Aphrodite deposits in quarter 2021, targeting the delivery of the DFS in the same quarter.
Ryan said: “We are now focused on completing our definitive feasibility study in Q1 2021 while continuing our expansive +40,000 metre exploration program targeting new discoveries, which should continue to generate news-flow right up until Christmas and into the early part of 2021.”
The company will also continue market engagement with potential lenders regarding project financing with a view to making a final investment decision in quarter three 2021.